Literature DB >> 22122992

Quality of life and the effect of memantine in dementia with lewy bodies and Parkinson's disease dementia.

Victoria Larsson1, Knut Engedal, Dag Aarsland, Carina Wattmo, Lennart Minthon, Elisabet Londos.   

Abstract

AIM: To investigate quality of life (QOL) and the effect of memantine treatment in patients with Lewy body dementias.
METHODS: A secondary analysis of a randomized controlled study in 70 patients with Parkinson's disease dementia (PDD) or dementia with Lewy bodies (DLB) over 24 weeks using caregiver-rated QOL-Alzheimer's disease (AD) in domains according to the WHO's classification of health.
RESULTS: Baseline QOL shows lower ratings for body functions over environmental factors in DLB/PDD. Treatment with memantine significantly improves life as a whole compared to placebo and improves total QOL, body function and structure.
CONCLUSION: This study shows that memantine improves QOL in Lewy body dementias. We also demonstrate important QOL patterns which can be used in clinical practice.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22122992     DOI: 10.1159/000334523

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  20 in total

Review 1.  Potentially inappropriate medications in the elderly: a comprehensive protocol.

Authors:  Suzana Mimica Matanović; Vera Vlahovic-Palcevski
Journal:  Eur J Clin Pharmacol       Date:  2012-02-24       Impact factor: 2.953

2.  Clinical trials of dementia with Lewy bodies and Parkinson's disease dementia.

Authors:  D Aarsland; C Ballard; A Rongve; M Broadstock; P Svenningsson
Journal:  Curr Neurol Neurosci Rep       Date:  2012-10       Impact factor: 5.081

Review 3.  Neuropsychiatric Issues in Parkinson's Disease.

Authors:  Jeffrey W Cooney; Mark Stacy
Journal:  Curr Neurol Neurosci Rep       Date:  2016-05       Impact factor: 5.081

Review 4.  New evidence on the management of Lewy body dementia.

Authors:  John-Paul Taylor; Ian G McKeith; David J Burn; Brad F Boeve; Daniel Weintraub; Claire Bamford; Louise M Allan; Alan J Thomas; John T O'Brien
Journal:  Lancet Neurol       Date:  2019-09-10       Impact factor: 44.182

5.  Interdisciplinary palliative care for people with advanced Parkinson's disease: a view from the home.

Authors:  Jori E Fleisher; Ellen C Klostermann; Serena P Hess; Jeanette Lee; Erica Myrick; Joshua Chodosh
Journal:  Ann Palliat Med       Date:  2019-10-14

6.  Outcome measures for Parkinson's disease dementia: a systematic review.

Authors:  Samantha K Holden; Wallace E Jones; Keith A Baker; Isabel M Boersma; Benzi M Kluger
Journal:  Mov Disord Clin Pract       Date:  2015-09-16

7.  Measuring quality of life in palliative care for Parkinson's disease: A clinimetric comparison.

Authors:  Samantha K Holden; Claire E Koljack; Lindsay P Prizer; Stefan H Sillau; Janis M Miyasaki; Benzi M Kluger
Journal:  Parkinsonism Relat Disord       Date:  2019-06-23       Impact factor: 4.891

8.  Systematic review and meta-analysis of combination therapy with cholinesterase inhibitors and memantine in Alzheimer's disease and other dementias.

Authors:  Taim Muayqil; Richard Camicioli
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2012-11-23

9.  Memantine and Cognition in Parkinson's Disease Dementia/Dementia With Lewy Bodies: A Meta-Analysis.

Authors:  Laura Brennan; Alexander Pantelyat; John E Duda; James F Morley; Daniel Weintraub; Jayne R Wilkinson; Paul J Moberg
Journal:  Mov Disord Clin Pract       Date:  2015-12-07

10.  Pre-Loss Grief in Caregivers of Older Adults with Dementia with Lewy Bodies.

Authors:  Juyoung Park; James E Galvin
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.